Treatment of a TaT1 high-grade tumour and a T2 tumour is completely
different; correct staging is therefore important. It has been demonstrated that a second TURB : - Increase recurrence-free survival (LE: 2a) - Improve outcomes after BCG treatment (LE: 3) - Provide prognostic information
Patients with BCG treated T1G3/HG tumours :
- improved recurrence-free survival - Progression-free survival (PFS) and - Overall survival (OS) only in patients without muscle in the specimen from initial resection Thanks